TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Tevogen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$6.77−0.30 (-4.24%)
Close on Oct 19, 2026
- Market cap
- $25.92M
- P/E (TTM)
- –
- Dividend yield
- –
Tevogen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Tevogen | Industry median |
|---|---|---|
| Market Cap | $44.08M | $166.30M |
| Enterprise Value | $43.00M | $88.19M |
Income (trailing twelve months)
| Measure | Tevogen | Industry median |
|---|---|---|
| Operating Income | -$21.40M | -$21.40M |
| Net Income | -$21.61M | -$22.46M |
| EBITDA | -$21.40M | -$16.91M |
| EPS (Diluted) | -$6.98 | -$0.83 |
Returns
| Measure | Tevogen | Industry median |
|---|---|---|
| Return on Assets (ROA) | -480.4% | -40.9% |
Balance sheet
| Measure | Tevogen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.08M | $61.43M |
| Net Cash (Debt) | $1.08M | $15.35M |
| Net Cash Per Share | $0.17 | $0.66 |
| Equity (Book Value) | -$8.89M | $49.09M |
| Book Value Per Share | -$1.37 | $1.37 |
| Tangible Book Value | -$8.89M | $23.52M |
| Working Capital | -$4.14M | $76.81M |
Financial position
| Measure | Tevogen | Industry median |
|---|---|---|
| Current Ratio | 0.33 | 3.34 |
| Quick Ratio | 0.18 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Tevogen | Industry median |
|---|---|---|
| Operating Cash Flow | -$11.57M | -$12.35M |
Dividends and yields
| Measure | Tevogen | Industry median |
|---|---|---|
| Earnings Yield | -49.0% | -23.3% |
Shares
| Measure | Tevogen | Industry median |
|---|---|---|
| Shares Outstanding | 6,511,540 | 58,127,000 |
| Shares Change (YoY) | 10.2% | 10.9% |
| Shares Change (QoQ) | 2.07% | 0.54% |
Scores
| Measure | Tevogen | Industry median |
|---|---|---|
| Altman Z-Score | -58.72 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Tevogen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.